Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04117321

Mother-infant Microbiota Transmission and Its Link to the Health of the Baby

Status
Recruiting
Phase
Study type
Observational
Enrollment
20,000 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The human intestinal tract harbors a diverse and complex microbial community, known as gut microbiota, which is critical in sustaining physiology, metabolism, nutrition and immune function. Dysbiosis of gut microbiota has been linked with obesity, hyperglycemia, hyperlipidemia, inflammatory bowel disease and other chronic inflammatory diseases. Gut microbiota is affected by host genetic markup, diet and life style; and therefore varied by human races and geographical locations. The development of gut microbiota starts before birth. The infant's microbiome can impact on human health in later life. The microbiome of pregnant women are associated with early-life microbiota of their offspring as well as growth, neurodevelopment and the development of allergic and neurocognitive disorders. Early childhood, when the microbiota is less mature and more malleable, is a golden age for microbiota manipulation to prevent disease. Studying microbiota at this golden age also allow us to dissect the development of a faulty microbiota and identify therapeutic targets to reverse it and cure diseases that are already developed.

Conditions

Timeline

Start date
2019-09-23
Primary completion
2026-10-02
Completion
2027-10-02
First posted
2019-10-07
Last updated
2024-05-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04117321. Inclusion in this directory is not an endorsement.

Mother-infant Microbiota Transmission and Its Link to the Health of the Baby (NCT04117321) · Clinical Trials Directory